Improved Therapeutic Effect against Leukemia by a Combination of the Histone Methyltransferase Inhibitor Chaetocin and the Histone Deacetylase Inhibitor Trichostatin A
Open Access
- 1 January 2013
- journal article
- Published by XMLink in Journal of Korean Medical Science
- Vol. 28 (2) , 237-246
Abstract
Tran HT, et al. J Korean Med Sci. 2013 Feb;28(2):237-246. https://doi.org/10.3346/jkms.2013.28.2.237Keywords
Funding Information
- Ministry of Health and Welfare (A111218-GM06)
- Environmental Health Center for Childhood Leukemia and Cancer, Chonnam National University Hwasun Hospital (HCRE/0035-6)
This publication has 37 references indexed in Scilit:
- DNA Methylation Changes Following 5-azacitidine Treatment in Patients with Myelodysplastic SyndromeJournal of Korean Medical Science, 2011
- Leukaemogenesis: more than mutant genesNature Reviews Cancer, 2010
- Deregulation of histone lysine methyltransferases contributes to oncogenic transformation of human bronchoepithelial cellsCancer Cell International, 2008
- Association of the SUV39H1 histone methyltransferase with the DNA methyltransferase 1 at mRNA expression level in primary colorectal cancerInternational Journal of Cancer, 2007
- Oncogene-induced senescence as an initial barrier in lymphoma developmentNature, 2005
- The history of cancer epigeneticsNature Reviews Cancer, 2004
- Methyl-CpG Binding Domain 1 (MBD1) Interacts with the Suv39h1-HP1 Heterochromatic Complex for DNA Methylation-based Transcriptional RepressionJournal of Biological Chemistry, 2003
- The many faces of histone lysine methylationCurrent Opinion in Cell Biology, 2002
- Tumor suppressor genes in normal and malignant hematopoiesisOncogene, 2002
- Functional and physical interaction between the histone methyl transferase Suv39H1 and histone deacetylasesNucleic Acids Research, 2002